Liver Transplantation for HCC in HIV-Infected Patients: Long-Term Single-Center Experience.

ABSTRACT: HIV-infected patients now have long life expectation since the introduction of the highly active antiretroviral therapy (HAART). Liver diseases, especially cirrhosis and hepatocellular carcinoma (HCC), currently represent a leading cause of death in this setting of patients. To address the results of liver transplantation (LT) for HCC in HIV-infected patients. All patients with and without HIV infection who underwent LT for HCC (n = 420) between 2001 and 2021 in our center were analyzed with the intent of comparing graft and patient survival. Cox regression analysis was used to determine prognostic survival factors and logistic regression to determine the predictor factors of post-LT recurrence. Among 1010 LT, 32 were HIV-infected recipients. With an average follow-up of 62 ± 51 months, 5-

SUBMITTER: Guerrini GP 

PROVIDER: S-EPMC8471924 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature